Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 158

1.

A cystic fibrosis child with lung function decline.

Fiscarelli EV, Ricciotti G, Rossitto M, Pompilio A, Tuccio Guarna Assanti V, Lucidi V.

J Cyst Fibros. 2019 Jul 9. pii: S1569-1993(19)30819-7. doi: 10.1016/j.jcf.2019.06.015. [Epub ahead of print]

PMID:
31300282
2.

Effectivenesss of ivacaftor in severe cystic fibrosis patients and non-G551D gating mutations.

Salvatore D, Carnovale V, Iacotucci P, Braggion C, Castellani C, Cimino G, Colangelo C, Francalanci M, Leonetti G, Lucidi V, Manca A, Vitullo P, Ferrara N.

Pediatr Pulmonol. 2019 Jun 25. doi: 10.1002/ppul.24424. [Epub ahead of print]

PMID:
31237430
3.

Genetic Polymorphisms Affecting IDO1 or IDO2 Activity Differently Associate With Aspergillosis in Humans.

Napolioni V, Pariano M, Borghi M, Oikonomou V, Galosi C, De Luca A, Stincardini C, Vacca C, Renga G, Lucidi V, Colombo C, Fiscarelli E, Lass-Flörl C, Carotti A, D'Amico L, Majo F, Russo MC, Ellemunter H, Spolzino A, Mosci P, Brancorsini S, Aversa F, Velardi A, Romani L, Costantini C.

Front Immunol. 2019 May 7;10:890. doi: 10.3389/fimmu.2019.00890. eCollection 2019.

4.

Methicillin-resistant Staphylococcus aureus eradication in cystic fibrosis patients: A randomized multicenter study.

Dolce D, Neri S, Grisotto L, Campana S, Ravenni N, Miselli F, Camera E, Zavataro L, Braggion C, Fiscarelli EV, Lucidi V, Cariani L, Girelli D, Faelli N, Colombo C, Lucanto C, Lombardo M, Magazzù G, Tosco A, Raia V, Manara S, Pasolli E, Armanini F, Segata N, Biggeri A, Taccetti G.

PLoS One. 2019 Mar 22;14(3):e0213497. doi: 10.1371/journal.pone.0213497. eCollection 2019.

5.

Unilateral Adrenalectomy Could Be a Valid Option for Primary Nodular Adrenal Disease: Evidence From Twins.

Kyrilli A, Lytrivi M, Bouquegneau MS, Demetter P, Lucidi V, Garcia C, Moreno-Reyes R, Tabarin A, Corvilain B, Driessens N.

J Endocr Soc. 2018 Oct 24;3(1):129-134. doi: 10.1210/js.2018-00261. eCollection 2019 Jan 1.

6.

Clinical expression of cystic fibrosis in a large cohort of Italian siblings.

Terlizzi V, Lucarelli M, Salvatore D, Angioni A, Bisogno A, Braggion C, Buzzetti R, Carnovale V, Casciaro R, Castaldo G, Cirilli N, Collura M, Colombo C, Di Lullo AM, Elce A, Lucidi V, Madarena E, Padoan R, Quattrucci S, Raia V, Seia M, Termini L, Zarrilli F.

BMC Pulm Med. 2018 Dec 22;18(1):196. doi: 10.1186/s12890-018-0766-6.

7.

Intraductal papillary neoplasm of the bile duct: A rare precursor of cholangiocarcinoma.

Verset L, Lucidi V, Demetter P.

Liver Int. 2019 Apr;39(4):777-778. doi: 10.1111/liv.14023. Epub 2019 Feb 27. No abstract available.

PMID:
30549408
8.

Gut microbiota signatures in cystic fibrosis: Loss of host CFTR function drives the microbiota enterophenotype.

Vernocchi P, Del Chierico F, Russo A, Majo F, Rossitto M, Valerio M, Casadei L, La Storia A, De Filippis F, Rizzo C, Manetti C, Paci P, Ercolini D, Marini F, Fiscarelli EV, Dallapiccola B, Lucidi V, Miccheli A, Putignani L.

PLoS One. 2018 Dec 6;13(12):e0208171. doi: 10.1371/journal.pone.0208171. eCollection 2018.

9.

LI-RADS: a great opportunity not to be missed.

Renzulli M, Clemente A, Brocchi S, Milandri M, Lucidi V, Vukotic R, Cappabianca S, Golfieri R.

Eur J Gastroenterol Hepatol. 2019 Mar;31(3):283-288. doi: 10.1097/MEG.0000000000001269. Review.

PMID:
30234643
10.

Trans-heterozygosity for mutations enhances the risk of recurrent/chronic pancreatitis in patients with Cystic Fibrosis.

Sofia VM, Surace C, Terlizzi V, Da Sacco L, Alghisi F, Angiolillo A, Braggion C, Cirilli N, Colombo C, Di Lullo A, Padoan R, Quattrucci S, Raia V, Tuccio G, Zarrilli F, Tomaiuolo AC, Novelli A, Lucidi V, Lucarelli M, Castaldo G, Angioni A.

Mol Med. 2018 Jul 27;24(1):38. doi: 10.1186/s10020-018-0041-6.

11.

Impact of biological agents on the prevalence of chemotherapy associated liver injury (CALI): Multicentric study of patients operated for colorectal liver metastases.

Hubert C, Lucidi V, Weerts J, Dili A, Demetter P, Massart B, Komuta M, Navez J, Reding R, Gigot JF, Sempoux C.

Eur J Surg Oncol. 2018 Oct;44(10):1532-1538. doi: 10.1016/j.ejso.2018.07.050. Epub 2018 Jul 27.

PMID:
30093084
12.

Pancreatic disorders in children: New clues on the horizon.

Della Corte C, Faraci S, Majo F, Lucidi V, Fishman DS, Nobili V.

Dig Liver Dis. 2018 Sep;50(9):886-893. doi: 10.1016/j.dld.2018.06.016. Epub 2018 Jun 27. Review.

PMID:
30007515
13.

Metabolomic Analysis by Nuclear Magnetic Resonance Spectroscopy as a New Approach to Understanding Inflammation and Monitoring of Pharmacological Therapy in Children and Young Adults With Cystic Fibrosis.

Montuschi P, Lucidi V, Paris D, Montemitro E, Shohreh R, Mores N, Melck D, Santini G, Majo F, Motta A.

Front Pharmacol. 2018 Jun 18;9:595. doi: 10.3389/fphar.2018.00595. eCollection 2018.

14.

The concept of oligometastases in colorectal cancer: from the clinical evidences to new therapeutic strategies.

Massaut E, Bohlok A, Lucidi V, Hendlisz A, Klastersky JA, Donckier V.

Curr Opin Oncol. 2018 Jul;30(4):262-268. doi: 10.1097/CCO.0000000000000453. Review.

PMID:
29746284
15.

Treatment compliance in cystic fibrosis patients with chronic Pseudomonas aeruginosa infection treated with tobramycin inhalation powder: The FREE study.

Blasi F, Carnovale V, Cimino G, Lucidi V, Salvatore D, Messore B, Bartezaghi M, Muscianisi E, Porpiglia PA; FREE study group.

Respir Med. 2018 May;138:88-94. doi: 10.1016/j.rmed.2018.03.034. Epub 2018 Mar 31.

PMID:
29724399
16.

Implementing carrier screening for cystic fibrosis outside the clinic: ethical analysis in the light of the personalist view.

Di Pietro ML, Teleman AA, Gonzalez-Melado FJ, Zace D, Di Raimo FR, Lucidi V, Refolo P.

Clin Ter. 2018 Mar-Apr;169(2):e71-e76. doi: 10.7417/T.2018.2057.

17.

Selective internal radiation therapy (SIRT) before partial hepatectomy or radiofrequency destruction for treatment of hepatocellular carcinoma in cirrhotic patients: a feasibility and safety pilot study.

Lemaire M, Lucidi V, Bouazza F, Katsanos G, Vanderlinden B, Levillain H, Delatte P, Garcia CA, Vouche M, Galdon MG, Demetter P, Deleporte A, Hendlisz A, Flamen P, Donckier V.

HPB (Oxford). 2018 Jul;20(7):641-648. doi: 10.1016/j.hpb.2018.01.006. Epub 2018 Feb 24.

18.

[Religious and cultural aspects of organ transplantation].

Janssen F, Richet I, Caekelberghs E, Attyia R, Gauthier M, Gergely T, Mayer M, Sosnowski M, Lucidi V, Berré J, Preiser JC.

Rev Med Brux. 2017;38(6):490-493. French.

PMID:
29318805
19.

A Metagenomic and in Silico Functional Prediction of Gut Microbiota Profiles May Concur in Discovering New Cystic Fibrosis Patient-Targeted Probiotics.

Vernocchi P, Del Chierico F, Quagliariello A, Ercolini D, Lucidi V, Putignani L.

Nutrients. 2017 Dec 9;9(12). pii: E1342. doi: 10.3390/nu9121342.

20.

Combination of Gene Expression Signature and Model for End-Stage Liver Disease Score Predicts Survival of Patients With Severe Alcoholic Hepatitis.

Trépo E, Goossens N, Fujiwara N, Song WM, Colaprico A, Marot A, Spahr L, Demetter P, Sempoux C, Im GY, Saldarriaga J, Gustot T, Devière J, Thung SN, Minsart C, Sersté T, Bontempi G, Abdelrahman K, Henrion J, Degré D, Lucidi V, Rubbia-Brandt L, Nair VD, Moreno C, Deltenre P, Hoshida Y, Franchimont D.

Gastroenterology. 2018 Mar;154(4):965-975. doi: 10.1053/j.gastro.2017.10.048. Epub 2017 Nov 20.

21.

Lack of efficacy of Lactobacillus GG in reducing pulmonary exacerbations and hospital admissions in children with cystic fibrosis: A randomised placebo controlled trial.

Bruzzese E, Raia V, Ruberto E, Scotto R, Giannattasio A, Bruzzese D, Cavicchi MC, Francalanci M, Colombo C, Faelli N, Daccò V, Magazzù G, Costa S, Lucidi V, Majo F, Guarino A.

J Cyst Fibros. 2018 May;17(3):375-382. doi: 10.1016/j.jcf.2017.10.014. Epub 2017 Nov 8.

PMID:
29128317
22.

A Different Microbiome Gene Repertoire in the Airways of Cystic Fibrosis Patients with Severe Lung Disease.

Bacci G, Mengoni A, Fiscarelli E, Segata N, Taccetti G, Dolce D, Paganin P, Morelli P, Tuccio V, De Alessandri A, Lucidi V, Bevivino A.

Int J Mol Sci. 2017 Jul 29;18(8). pii: E1654. doi: 10.3390/ijms18081654.

23.

Long-term outcomes of patients with 10 or more colorectal liver metastases.

Allard MA, Adam R, Giuliante F, Lapointe R, Hubert C, Ijzermans JNM, Mirza DF, Elias D, Laurent C, Gruenberger T, Poston G, Letoublon C, Isoniemi H, Lucidi V, Popescu I, Figueras J.

Br J Cancer. 2017 Aug 22;117(5):604-611. doi: 10.1038/bjc.2017.218. Epub 2017 Jul 20.

24.

Liposomes loaded with bioactive lipids enhance antibacterial innate immunity irrespective of drug resistance.

Poerio N, Bugli F, Taus F, Santucci MB, Rodolfo C, Cecconi F, Torelli R, Varone F, Inchingolo R, Majo F, Lucidi V, Mariotti S, Nisini R, Sanguinetti M, Fraziano M.

Sci Rep. 2017 Mar 27;7:45120. doi: 10.1038/srep45120.

25.

The interval approach: an adaptation of the liver-first approach to treat synchronous liver metastases from rectal cancer.

D'Hondt M, Lucidi V, Vermeiren K, Van Den Bossche B, Donckier V, Sergeant G.

World J Surg Oncol. 2017 Mar 2;15(1):54. doi: 10.1186/s12957-017-1123-6.

26.

A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosis.

Moretti S, Renga G, Oikonomou V, Galosi C, Pariano M, Iannitti RG, Borghi M, Puccetti M, De Zuani M, Pucillo CE, Paolicelli G, Zelante T, Renauld JC, Bereshchenko O, Sportoletti P, Lucidi V, Russo MC, Colombo C, Fiscarelli E, Lass-Flörl C, Majo F, Ricciotti G, Ellemunter H, Ratclif L, Talesa VN, Napolioni V, Romani L.

Nat Commun. 2017 Jan 16;8:14017. doi: 10.1038/ncomms14017.

27.

Changes of CFTR functional measurements and clinical improvements in cystic fibrosis patients with non p.Gly551Asp gating mutations treated with ivacaftor.

Mesbahi M, Shteinberg M, Wilschanski M, Hatton A, Nguyen-Khoa T, Friedman H, Cohen M, Escabasse V, Le Bourgeois M, Lucidi V, Sermet-Gaudelus I, Bassinet L, Livnat G.

J Cyst Fibros. 2017 Jan;16(1):45-48. doi: 10.1016/j.jcf.2016.08.006. Epub 2016 Sep 20.

28.

Genotype-phenotype correlation and functional studies in patients with cystic fibrosis bearing CFTR complex alleles.

Terlizzi V, Castaldo G, Salvatore D, Lucarelli M, Raia V, Angioni A, Carnovale V, Cirilli N, Casciaro R, Colombo C, Di Lullo AM, Elce A, Iacotucci P, Comegna M, Scorza M, Lucidi V, Perfetti A, Cimino R, Quattrucci S, Seia M, Sofia VM, Zarrilli F, Amato F.

J Med Genet. 2017 Apr;54(4):224-235. doi: 10.1136/jmedgenet-2016-103985. Epub 2016 Oct 13.

29.

Fungal infections of the lung in children.

Toma P, Bertaina A, Castagnola E, Colafati GS, D'Andrea ML, Finocchi A, Lucidi V, Mastronuzzi A, Granata C.

Pediatr Radiol. 2016 Dec;46(13):1856-1865. Epub 2016 Sep 23. Review.

PMID:
27663906
30.

The practice of laparoscopic liver surgery in Belgium: a national survey.

Tomassini F, Scuderi V, Berardi G, Dili A, D'Hondt M, Sergeant G, Hubert C, Huysentruyt F, Berrevoet F, Lucidi V, Troisi RI.

Acta Chir Belg. 2017 Feb;117(1):15-20. doi: 10.1080/00015458.2016.1202478. Epub 2016 Aug 19.

PMID:
27541973
31.

Correction: Pyrosequencing Unveils Cystic Fibrosis Lung Microbiome Differences Associated with a Severe Lung Function Decline.

Bacci G, Paganin P, Lopez L, Vanni C, Dalmastri C, Cantale C, Daddiego L, Perrotta G, Dolce D, Morelli P, Tuccio V, De Alessandri A, Fiscarelli EV, Taccetti G, Lucidi V, Bevivino A, Mengoni A.

PLoS One. 2016 Aug 1;11(8):e0160726. doi: 10.1371/journal.pone.0160726. eCollection 2016.

32.

Pyrosequencing Unveils Cystic Fibrosis Lung Microbiome Differences Associated with a Severe Lung Function Decline.

Bacci G, Paganin P, Lopez L, Vanni C, Dalmastri C, Cantale C, Daddiego L, Perrotta G, Dolce D, Morelli P, Tuccio V, De Alessandri A, Fiscarelli EV, Taccetti G, Lucidi V, Bevivino A, Mengoni A.

PLoS One. 2016 Jun 29;11(6):e0156807. doi: 10.1371/journal.pone.0156807. eCollection 2016. Erratum in: PLoS One. 2016;11(8):e0160726.

33.

Extensive molecular analysis suggested the strong genetic heterogeneity of idiopathic chronic pancreatitis.

Sofia VM, Da Sacco L, Surace C, Tomaiuolo AC, Genovese S, Grotta S, Gnazzo M, Ciocca L, Petrocchi S, Alghisi F, Montemitro E, Martemucci L, Elce A, Lucidi V, Castaldo G, Angioni A.

Mol Med. 2016 Sep;22:300-309. doi: 10.2119/molmed.2016.00010. Epub 2016 May 26.

34.

Missing metastases as a model to challenge current therapeutic algorithms in colorectal liver metastases.

Lucidi V, Hendlisz A, Van Laethem JL, Donckier V.

World J Gastroenterol. 2016 Apr 21;22(15):3937-44. doi: 10.3748/wjg.v22.i15.3937. Review.

35.

Longterm results of liver transplantation from donation after circulatory death.

Blok JJ, Detry O, Putter H, Rogiers X, Porte RJ, van Hoek B, Pirenne J, Metselaar HJ, Lerut JP, Ysebaert DK, Lucidi V, Troisi RI, Samuel U, den Dulk AC, Ringers J, Braat AE; Eurotransplant Liver Intestine Advisory Committee.

Liver Transpl. 2016 Aug;22(8):1107-14. doi: 10.1002/lt.24449.

36.

IL-1 receptor antagonist ameliorates inflammasome-dependent inflammation in murine and human cystic fibrosis.

Iannitti RG, Napolioni V, Oikonomou V, De Luca A, Galosi C, Pariano M, Massi-Benedetti C, Borghi M, Puccetti M, Lucidi V, Colombo C, Fiscarelli E, Lass-Flörl C, Majo F, Cariani L, Russo M, Porcaro L, Ricciotti G, Ellemunter H, Ratclif L, De Benedictis FM, Talesa VN, Dinarello CA, van de Veerdonk FL, Romani L.

Nat Commun. 2016 Mar 14;7:10791. doi: 10.1038/ncomms10791.

37.

Caregiver burden and vocational participation among parents of adolescents with CF.

Neri L, Lucidi V, Catastini P, Colombo C; LINFA Study Group.

Pediatr Pulmonol. 2016 Mar;51(3):243-52. doi: 10.1002/ppul.23352. Epub 2015 Dec 22.

PMID:
26694093
38.

Nonalcoholic fatty pancreas disease and Nonalcoholic fatty liver disease: more than ectopic fat.

Della Corte C, Mosca A, Majo F, Lucidi V, Panera N, Giglioni E, Monti L, Stronati L, Alisi A, Nobili V.

Clin Endocrinol (Oxf). 2015 Nov;83(5):656-62. doi: 10.1111/cen.12862. Epub 2015 Aug 12.

PMID:
26201937
39.

Analysis of aquaporin expression in liver with a focus on hepatocytes.

Gregoire F, Lucidi V, Zerrad-Saadi A, Virreira M, Bolaky N, Delforge V, Lemmers A, Donckier V, Devière J, Demetter P, Perret J, Delporte C.

Histochem Cell Biol. 2015 Oct;144(4):347-63. doi: 10.1007/s00418-015-1341-3. Epub 2015 Jul 1.

PMID:
26126651
40.

Changes in cystic fibrosis airway microbial community associated with a severe decline in lung function.

Paganin P, Fiscarelli EV, Tuccio V, Chiancianesi M, Bacci G, Morelli P, Dolce D, Dalmastri C, De Alessandri A, Lucidi V, Taccetti G, Mengoni A, Bevivino A.

PLoS One. 2015 Apr 21;10(4):e0124348. doi: 10.1371/journal.pone.0124348. eCollection 2015.

41.

Liver transplantation in the context of organ shortage: toward extension and restriction of indications considering recent clinical data and ethical framework.

Lucidi V, Gustot T, Moreno C, Donckier V.

Curr Opin Crit Care. 2015 Apr;21(2):163-70. doi: 10.1097/MCC.0000000000000186. Review.

PMID:
25692807
42.

Relationship between CFTR and CTRC variants and the clinical phenotype in late-onset cystic fibrosis disease with chronic pancreatitis.

Tomaiuolo AC, Sofia VM, Surace C, Majo F, Genovese S, Petrocchi S, Grotta S, Alghisi F, Lucidi V, Angioni A.

J Mol Diagn. 2015 Mar;17(2):171-8. doi: 10.1016/j.jmoldx.2014.11.007. Epub 2015 Jan 28.

PMID:
25636364
43.

Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): impact of the inter-stages course on morbi-mortality and implications for management.

Truant S, Scatton O, Dokmak S, Regimbeau JM, Lucidi V, Laurent A, Gauzolino R, Castro Benitez C, Pequignot A, Donckier V, Lim C, Blanleuil ML, Brustia R, Le Treut YP, Soubrane O, Azoulay D, Farges O, Adam R, Pruvot FR; e-HPBchir Study Group from the Association de Chirurgie Hépato-Biliaire et de Transplantation (ACHBT).

Eur J Surg Oncol. 2015 May;41(5):674-82. doi: 10.1016/j.ejso.2015.01.004. Epub 2015 Jan 17.

PMID:
25630689
44.

Clinical expression of patients with the D1152H CFTR mutation.

Terlizzi V, Carnovale V, Castaldo G, Castellani C, Cirilli N, Colombo C, Corti F, Cresta F, D'Adda A, Lucarelli M, Lucidi V, Macchiaroli A, Madarena E, Padoan R, Quattrucci S, Salvatore D, Zarrilli F, Raia V.

J Cyst Fibros. 2015 Jul;14(4):447-52. doi: 10.1016/j.jcf.2014.12.012. Epub 2015 Jan 10.

45.

Nuclear magnetic resonance-based metabolomics discriminates primary ciliary dyskinesia from cystic fibrosis.

Montuschi P, Paris D, Montella S, Melck D, Mirra V, Santini G, Mores N, Montemitro E, Majo F, Lucidi V, Bush A, Motta A, Santamaria F.

Am J Respir Crit Care Med. 2014 Jul 15;190(2):229-33. doi: 10.1164/rccm.201402-0249LE. No abstract available.

PMID:
25025356
46.

Reply to: "liver transplantation and severe acute alcoholic hepatitis: an ethical consideration".

Donckier V, Lucidi V, Gustot T, Moreno C.

J Hepatol. 2014 Sep;61(3):707. doi: 10.1016/j.jhep.2014.05.029. Epub 2014 Jun 2. No abstract available.

47.

Cystic fibrosis: a surgical matter?

Caldaro T, Alghisi F, De Angelis P, Garganese MC, Rea F, Pizzoferro M, Villani MF, Romeo EF, Torroni F, Foschia F, Gambitta RA, Federici G, Lucidi V, Dall'Oglio L.

J Pediatr Surg. 2014 May;49(5):753-8. doi: 10.1016/j.jpedsurg.2014.02.089. Epub 2014 Mar 29.

PMID:
24851763
48.

Glucose tolerance affects pubertal growth and final height of children with cystic fibrosis.

Bizzarri C, Montemitro E, Pedicelli S, Ciccone S, Majo F, Cappa M, Lucidi V.

Pediatr Pulmonol. 2015 Feb;50(2):144-9. doi: 10.1002/ppul.23042. Epub 2014 Mar 28.

PMID:
24678051
49.

Treatment of low bone density in young people with cystic fibrosis: a multicentre, prospective, open-label observational study of calcium and calcifediol followed by a randomised placebo-controlled trial of alendronate.

Bianchi ML, Colombo C, Assael BM, Dubini A, Lombardo M, Quattrucci S, Bella S, Collura M, Messore B, Raia V, Poli F, Bini R, Albanese CV, De Rose V, Costantini D, Romano G, Pustorino E, Magazzù G, Bertasi S, Lucidi V, Traverso G, Coruzzo A, Grzejdziak AD.

Lancet Respir Med. 2013 Jul;1(5):377-85. doi: 10.1016/S2213-2600(13)70064-X. Epub 2013 Jun 2.

PMID:
24429202
50.

Ethical considerations regarding early liver transplantation in patients with severe alcoholic hepatitis not responding to medical therapy.

Donckier V, Lucidi V, Gustot T, Moreno C.

J Hepatol. 2014 Apr;60(4):866-71. doi: 10.1016/j.jhep.2013.11.015. Epub 2013 Nov 26. Review.

Supplemental Content

Loading ...
Support Center